Tunable control of B. infantis abundance and gut metabolites by co-administration of human milk oligosaccharides

Tunable control of B. infantis abundance and gut metabolites by co-administration of human milk oligosaccharides

ABSTRACTPrecision engineering of the gut microbiome holds promise as an effective therapeutic approach for diseases associated with a disruption in this microbial community. Engrafting a live biotherapeutic product (LBP) in a predictable, controllable manner is key to the consistent success of this...

Full description

Bibliographic Details
Main Authors: Abigail L. Reens, Casey M. Cosetta, Russell Saur, Olivia Trofimuk, Sarah L. Brooker, Martin L. Lee, Adam K. Sun, Gregory J. McKenzie, Julie E. Button
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Gut Microbes
Subjects:
Gut microbiome
gut microbiota
microbiome modulation
Live biotherapeutic product (LBP)
synbiotic
Bifidobacterium
Online Access:https://www.tandfonline.com/doi/10.1080/19490976.2024.2304160

Internet

https://www.tandfonline.com/doi/10.1080/19490976.2024.2304160

Similar Items